ASML reported €38.8 billion backlog amid political pressure over export controls and advanced packaging capacity constraints.

ASML's stock has spent the past week whipsawing between analyst euphoria and geopolitical dread, a fitting prelude to the quarterly earnings report due on July 15 that will test which narrative prevails. The Dutch chip-equipment giant closed Friday at €1,574.20, down 0.51% on the day and 3.30% lower on the week—a mild pullback that barely registers against a 12-month gain of 128.94% and year-to-date advance of 59.28%.

The short-term retrenchment has been anything but quiet. On July 7, disappointing preliminary figures from Samsung Electronics triggered a sector-wide sell-off, followed by fresh anxiety over tightening export controls. The Dutch government joined a US-led alliance pushing to extend restrictions beyond ASML's extreme ultraviolet (EUV) lithography systems to include deep ultraviolet (DUV) immersion tools and even service contracts—putting roughly one-fifth of ASML's planned China system revenue at risk.

Then, just 48 hours later, sentiment reversed. Global memory-chip makers confirmed their capital expenditure budgets for ASML systems through 2027, triggering a fresh wave of analyst upgrades. Bernstein's David Dai lifted his price target by 33% to $2,623, citing additional sales from AI-driven demand. Morgan Stanley raised its target to €1,830 on July 7, and J.P. Morgan added its own buy recommendation. Wall Street consensus stands at "Strong Buy" based on eight buy ratings in the past three months.

Yet a separate political development is casting a longer shadow. The so-called MATCH Act, introduced in the US House on April 2 by Representative Michael Baumgartner and advanced through committee on April 22, seeks to dramatically expand export curbs on ASML's DUV immersion machines—technology China is still allowed to purchase and service. A companion Senate bill remains under discussion with nothing yet enacted. ASML management has already built in some buffer: the 2026 revenue guidance range of €36 billion to €40 billion, as CEO Christophe Fouquet stated, already accounts for "possible outcomes of the ongoing discussions around export controls."

The real question is whether that buffer proves sufficient. China's share of net system revenue tumbled to 19% in the first quarter of 2026, down from 36% in the prior quarter, while South Korea's share surged to 45%. ASML expects China to settle at roughly 20% for the full year—suggesting the company is already diversifying away from its most geopolitically exposed market. The structural bull case rests on a backlog that stood at €38.8 billion at the end of 2025, stretching out to 2027 and beyond. Full-year 2025 revenue hit €32.7 billion, up 15.6%, with net profit of €9.6 billion and gross margin of 52.8%.

Even so, valuation remains a nagging concern. ASML trades well above historical multiples, leaving little margin for error. Some observers note the stock is acutely sensitive to any wobble in AI capital expenditure plans or macroeconomic surprises. Adding a technical complication, leading chipmakers including TSMC are reportedly delaying adoption of ASML's newest High-NA EUV generation, preferring cheaper alternatives to immediate upgrades. The company's capacity targets are ambitious: at least 60 Low-NA EUV systems this year, climbing to a minimum of 80 in 2027, up from 44 delivered in 2025—though these represent intentions rather than contracted orders, and supply-chain bottlenecks or demand corrections could slow the ramp.

At €1,574.20, the stock sits 9.94% below its 52-week high of €1,748.00 reached on June 30, yet well above both its 50-day moving average of €1,477.77 and 200-day moving average of €1,166.58—a 34.94% premium testifying to a robust long-term uptrend. The 14-day relative strength index sits at a neutral 51.1, offering no directional signal. With annualized 30-day volatility of 64.27%, the swings around the July 15 earnings could prove violent in either direction.

For the bulls, the earnings report must confirm that the order book for 2027 is intact across both EUV and DUV lines, and that revenue guidance is conservative enough to absorb any escalation in export restrictions. For the bears, the risk is that the MATCH Act advances toward passage in its current form, threatening not just new equipment sales but also the high-margin service and upgrade revenue from ASML's installed base in China. That recurring stream represents exactly the part of the business most vulnerable to a tightened regulatory regime. As CFO Roger Dassen noted on the first-quarter call, the company can "absorb within the range of €36 billion to €40 billion" the effects of the export-control debate—but the lower end of that range is not far away. The next two weeks will determine whether the political storm is a manageable headwind or a serious drag on a machine that has delivered 129% gains in a year.